PEA Protocol

Palmitoylethanolamide (PEA) is a natural compound your body makes when dealing with injury or stress.

It was first isolated in 1957 from everyday foods like soy, egg yolks, and peanuts.

Your body produces PEA as part of its natural defence system, working alongside the endocannabinoid system to manage pain and inflammation.

The compound gained serious research attention in 1993 when Nobel Prize winner Rita Levi-Montalcini discovered how it controls mast cells - the immune cells that trigger inflammation.

Research shows PEA works by calming down overactive immune cells and nerve support cells, which reduces both inflammation and pain signals, especially nerve pain.

With extensive clinical documentation spanning over 60 years, PEA has become one of the most thoroughly studied natural pain and inflammation compounds available.

Reduces chronic pain effectively, with multiple large-scale studies showing significant improvements.

Offers powerful anti-inflammatory effects whilst maintaining an exceptional safety record with virtually no reported side effects.

Provides neuroprotective benefits that support brain health and may help with neurodegenerative conditions.

Shows promising effects as an alternative to long-term opioid use, potentially reducing dependency risks.

Use micronised or ultra-micronised PEA formulations at appropriate doses with proper cycling protocols to maximise benefits whilst maintaining the compound's excellent safety profile.